Category : Science and TechPublished on: November 15 2023
Share on facebook
The world's first chikungunya vaccine has been developed by France in November, 2023.
This vaccine has been developed by the French company 'Valneva'.
This vaccine has been named 'IXCHIQ'.
This vaccine has been approved by the United States.
The US Food and Drug Administration (FDA) confirmed the approval of the vaccine, saying that the vaccine can be given to people 18 years of age and older.
A single dose of Ixchik can be given through injection into the muscle.
Chikungunya virus is spread to humans mainly through the bite of an infected mosquito.
In this disease, there is fever, joint pain, headache, swelling in joints, and rashes on the skin.
